![Logo for Seres Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F2cc67-2023-01-02-04-02-45.png&w=256&q=100)
Seres Therapeutics Investor Relations Material
Latest events
![Logo for Seres Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F2cc67-2023-01-02-04-02-45.png&w=128&q=100)
Q1 2024
Seres Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Seres Therapeutics Inc
Access all reports
Seres Therapeutics, Inc. is a microbiome therapeutics platform company that engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate which has completed Phase III clinical trial for the treatment of CDI. It also develops SER-155 and SER-287 which are in Phase Ib clinical trial to reduce incidences of gastrointestinal infections and ulcerative colitis; SER-301 that is in Phase Ib clinical trial to treat metastatic melanoma; and SER-262 to treat Clostridioides difficile infection.
Key slides for Seres Therapeutics Inc
![HCP Enthusiasm for V](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fseres-therapeutics-inc-investor-presentation-c6efccb1c738bb22%2F11.png&w=3840&q=75)
![Logo for Seres Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F2cc67-2023-01-02-04-02-45.png&w=128&q=100)
Investor Presentation
Seres Therapeutics Inc
![Antimicrobial Resist](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fseres-therapeutics-inc-investor-presentation-c6efccb1c738bb22%2F20.png&w=3840&q=75)
![Logo for Seres Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F2cc67-2023-01-02-04-02-45.png&w=128&q=100)
Investor Presentation
Seres Therapeutics Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
MCRB
Country
🇺🇸 United States